Regenerative Expertise Target Regenity as a potential partner for contract manufacturing and development of bioabsorbable materials, highlighting their 30 years of experience and extensive product portfolio to support medtech manufacturers seeking regenerative solutions.

Bioabsorbable Portfolio Opportunity to collaborate on growth initiatives leveraging Regenity’s expanded portfolio after acquiring Polyganics, offering versatile resorbable polymer technologies that align with devices requiring temporary scaffolds or tissue repair components.

Global Footprint Emphasize the company’s multi-site manufacturing presence in the US and Netherlands to support regional supply chains, scale manufacturing capabilities, and reduce time-to-market for international medical device partners.

Financial Validation Revenue range positions Regenity as a mid-market supplier with potential for strategic partner programs, volume-based pricing, and co-development deals with emphasis on scalable production for growing medtech clients.

Mission Alignment Align sales conversations with Regenity’s patient-outcome focus and urgency-driven culture to explore partnerships on high-impact regenerative devices, enabling faster adoption of novel bioabsorbable solutions.